Chargement en cours...

Enhancing poxvirus vectors vaccine immunogenicity

Attenuated recombinant poxvirus vectors expressing heterologous antigens from pathogens are currently at various stages in clinical trials with the aim to establish their efficacy. This is because these vectors have shown excellent safety profiles, significant immunogenicity against foreign expresse...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: García-Arriaza, Juan, Esteban, Mariano
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896794/
https://ncbi.nlm.nih.gov/pubmed/25424927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.28974
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!